Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • David [R]
    Member
    • Jul 2012
    • 12

    #1

    edgeR, "DGELIst" function, "group" parameter

    Hi,

    I am using edgeR for some RNASeq analysis. My question concerns the DGEList function and its "group" parameter. I realized that, whether doing group=mydesignfactor or group=rep(1,ncol(counts)), the cpm numbers that I get after
    counts.TMM <- calcNormFactors(counts.DGEList)
    cpm.TMM=cpm(counts.TMM, normalized.lib.sizes=TRUE)
    are strictly identical in either case. The only difference between both ways is that the counts.TMM$samples$group column duly reflects what I put in in "group".

    Is this normal? What is it that I am missing? Is the "group" nevertheless taken into account on the subsequent estimateGLMCommonDisp, estimateGLMTrendDisp, estimateGLMTagDisp, glmFit, glmLRT etc.?

    Thanks in advance for your help.

    Best,

    David Rengel
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    There's no reason that cpm should be dependent upon your experimental design (in fact, it shouldn't be). The various GLM function pay attention to the design, since that's where it's important.

    Comment

    • David [R]
      Member
      • Jul 2012
      • 12

      #3
      Hi dpryan,

      THanks for your reply. Yes, that is right. My only only doubt came from de fact that if normalized.lib.sizes=TRUE, then the cpm are calculated using the normalization factors, which I thought were somehow dependent on your experimental design, but it seems I was mistaken.

      David

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Correct, normalization factors are independent from experimental design.

        Comment

        • David [R]
          Member
          • Jul 2012
          • 12

          #5
          Thanks a lot!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            Yesterday, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 10:52 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 05:39 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Working...